You are here

P&T News

April 21

New research supports previous findings
Over-the-counter compounds may replace damaged cells
Less than a third report seeing information comparing doctors, hospitals
Report calls for better treatment, awareness, research
Ninety-five percent of plans require prior authorization for DMARDs

April 20

New technology brings specialists to the bedside
FDA considers therapy for von Willebrand disease

April 17

Pivotal phase III data to be presented at neurology meeting
Nurse-led innovations save more than $28 million annually nationwide, association says
Cancer specialists examine future payment models to improve care and lower costs
Sandoz makes a move on Teva’s immune modifier
Median progression-free survival is 13.5 months for AZD9291

April 16

But some Medicare doctors still face temporary pay cuts
Centers judged on patients' satisfaction
Treatment indicated to reduce risk of hospitalization
Risk is dose-dependent for simvastatin and atorvastatin
Specialty societies give ‘thumbs down’ to low-benefit, high-cost preoperative testing

Pages